Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended 16 Months Ended 21 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2016
Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:                          
Net income (loss)                 $ 44,713 $ (151,710) $ 82,538    
Adjustments to reconcile net income (loss) to net cash flows from operating activities:                          
Depreciation expense                 31,825 24,997 15,255    
Amortization expense of assets and liabilities, net                 1,052 570 541    
Accretion of asset retirement obligations                 78 72 67    
Accretion of convertible note discount                 5,147 4,699 2,635    
Accretion of marketable securities                 0 189 553    
Impairment of property, plant and equipment, net $ 17,893 $ 0 $ 0 $ 0         17,893 0 0    
Provision for doubtful accounts                 630 (803) 1,453    
Stock compensation expense                 5,896 5,161 5,883    
Impairment of goodwill         $ 175,028 $ 0 $ 0 $ 0 0 175,028 0    
Impairment of investment                 0 1,915 0    
Deferred tax expense (benefits)                 3,009 (8,953) 3,641    
Change in fair value of contingent consideration                 7,904 (359) (6,631)    
Gain on involuntary conversion                 (9,894) 0 0 $ (1,525) $ (8,010)
Bargain purchase gain                 0 (5,358) 0    
Change in fair value of convertible debt conversion liability                 (13,045) 0 0    
Gain on debt extinguishment                 (2,331) 0 0    
Other                 (70) (231) 249    
Changes in asset and liabilities, net of effects from mergers and acquisitions:                          
Accounts receivable                 145,068 (20,309) (207,877)    
Inventories                 (58,551) 29,631 (277)    
Prepaid expenses and other assets                 (5,566) 16,315 (12,146)    
Accounts payable                 (133,139) 32,422 143,131    
Accrued expenses and other liabilities                 7,771 (6,769) 2,336    
Deferred revenue                 26,913 (16,347) 1,177    
Net cash flows provided from operating activities                 75,303 80,160 32,528    
CASH FLOWS FROM INVESTING ACTIVITIES:                          
Cash paid for marketable securities                 0 (52,435) (80,974)    
Cash receipts from marketable securities                 0 68,979 63,840    
Cash paid for purchase of property, plant and equipment                 (60,705) (64,477) (60,163)    
Insurance proceeds for asset impairments                 10,949 11,027 0    
Cash receipts from disposal of fixed assets                 0 0 45    
Transfer into restricted cash                 0 (4,000) (117,660)    
Transfer out of restricted cash                 1,960 15,845 0    
Cash paid for investments                 (3,249) (1,452) (2,779)    
Cash paid for acquisitions and additional interests, net of cash acquired                 (12,720) (41,409) (19,369)    
Other investing activities                 0 0 27    
Net cash flows used in investing activities                 (63,765) (67,922) (217,033)    
CASH FLOWS FROM FINANCING ACTIVITIES:                          
Net borrowings on line of credit                 26,445 6,470 5,693    
Borrowing on other lines of credit                 10,185 0 0    
Repayments on other lines of credits                 (2,437) 0 0    
Cash received for issuance of debt                 11,775 104 5,490    
Cash paid for capped call transactions                 0 0 (11,904)    
Cash received on convertible debt                 152,000 0 143,750    
Cash paid on debt                 (74,562) (6,708) (37,798)    
Cash paid for debt issuance costs                 (6,369) (542) (4,719)    
Cash received on partial termination of capped call options                 159 0 0    
Cash paid for issuance of common stock and preferred stock                 0 0 (1,587)    
Cash paid for redemption of preferred stock                 0 0 (3,562)    
Cash paid for treasury stock                 (51,474) (24,350) (529)    
Cash paid for contingent consideration                 (7,548) (2,248) 0    
Cash paid for preferred stock dividends                 0 0 (40)    
Net cash flows provided from (used in) financing activities                 58,174 (27,274) 94,794    
NET CHANGE IN CASH AND CASH EQUIVALENTS                 69,712 (15,036) (89,711)    
CASH AND CASH EQUIVALENTS, Beginning of period       $ 47,081       $ 63,516 47,081 63,516 153,227    
Effect of exchange rate changes on cash                 (583) (1,399) 0    
CASH AND CASH EQUIVALENTS, End of period 116,210       47,081       116,210 47,081 63,516 116,210 116,210
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:                          
Cash paid (received) for income taxes                 410 (189) (1,847)    
Cash paid for interest                 9,920 6,947 4,065    
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:                          
Common stock repurchased included in accrued expenses and other liabilities                 0 464 526    
Amounts included in period-end accounts payable for:                          
Purchases of property, plant and equipment                 3,833 7,734 4,220    
Issuance costs                 250 84 311    
Incentive common stock liability for supply agreement                 0 316 412    
Issuance of common stock for acquisitions                 4,050 15,310 80,163    
Contingent consideration for acquisitions                 4,500 5,000 45,950    
Debt assumed in acquisition $ 0       $ 5,225       0 5,225 129,745 $ 0 $ 0
Release of restricted cash to pay off the GOZone Bonds                 101,315 0 0    
Repayment of GOZone Bonds                 100,000 0 0    
Non-cash transfer of line of credit to long-term debt                 4,498 0 0    
Non-cash allocation of proceeds from the 2036 Convertible Notes issuance to convertible debt conversion liability                 40,145 0 0    
Non-cash allocation of purchase price between debt and equity related to the repurchase of the 2019 Convertible Notes                 7,387 0 0    
Non-cash share repurchases from partial capped call termination                 1,588 0 0    
Gain on redemption of preferred stock                 0 0 378    
Accruals of insurance proceeds related to impairment of property, plant and equipment                 $ 313 $ 1,414 $ 0